Longevity Protein Klotho May Protect Against Cognitive Decline in Parkinson's
This study suggests klotho-related therapies could one day target cognitive decline in Parkinson's.
People with Parkinson's disease who carry a specific variant of the klotho gene tended to perform better on executive thinking tasks across two separate groups. In mice engineered to model Parkinson's, boosting klotho levels improved brain function and reduced alpha-synuclein (a toxic protein that builds up in Parkinson's). The cognitive benefits showed up without improving motor symptoms. Lab experiments suggested klotho may work by helping brain cells clear that toxic protein more effectively.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
Related Studies
All researchHow Curcumin Protects Brain Cells in Parkinson's Mouse Models
In mice and cells made to mimic Parkinson's, curcumin protected the brain cells that make dopamine.
Curcumin May Sharpen Memory and Attention, Especially in Older Adults
Curcumin, the yellow compound in turmeric, keeps showing up in brain research for its anti-inflammatory effects.
Exercise Beats Brain Games for Protecting Aging Minds, Review Finds
Researchers looked at trials in poorer countries for people with early memory problems.
